We therefore studied tumour specimens from 54 patients with CUP enrolled in one of a large prospective randomised phase II trial (Culine et al, 2003) to determine EGFR, Her-2/neu, and c-Kit protein expression. This evidence concerns the gene EGFR and neoplasm.